Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for... see more

CSE:AION - Post Discussion

Aion Therapeutic Inc > Apollon Acquires Intellectual Property from Aion
View:
Comment by nightowl21 on May 05, 2022 10:41am
Hmm...tells me that a Pharma Company is likely interested in making a deal with Appollon...so Apollon needs control of Patents! Nice to see something happening.. not sure that getting 4 million shares of Apollon is a big deal!  Why isn’t this posted on Aion site.....and no impact on Aion shares being traded!
Comment by nightowl21 on May 05, 2022 11:28pm
I hope a few other shareholders dig into the substance of this news release! 1. UK Apollon has approx 700 million shares outstanding.....and they are giving Aion      Regular shareholders 4.0 million shares as partial payment to give up        Our rights to these patents! 2. The Royalty as stated is 4.0% of  Net Revenue!....usually royalties are paid out & ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities